---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-111279"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:30:12.091621+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical enters Conversion and Waiver Agreement with sponsor, modifying preferred stock terms and converting shares

## Summary
- Sponsor Anzu waives $3,733,333 in accrued dividends on Series A Preferred Stock.
- Envoy waives vesting restrictions on 1,000,000 restricted shares held by Anzu.
- Conversion price on Preferred Stock temporarily reduced from $11.50 to $3.63 per share through Jan 20, 2025.
- Anzu converts 373,333 Preferred Stock shares into 1,028,986 shares of common stock.
- Agreement executed December 20, 2024, closing same day.

## SEC filing metadata
- accession: 0001213900-24-111279
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390024111279/0001213900-24-111279-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390024111279/ea0225604-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-111279
- JSON: https://secwatch.observer/filing/0001213900-24-111279.json
- Plain text: https://secwatch.observer/filing/0001213900-24-111279.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.